首页> 外文期刊>BMC Genomics >Power estimation and sample size determination for replication studies of genome-wide association studies
【24h】

Power estimation and sample size determination for replication studies of genome-wide association studies

机译:用于全基因组关联研究的复制研究的功效估计和样本大小确定

获取原文
           

摘要

Replication study is a commonly used verification method to filter out false positives in genome-wide association studies (GWAS). If an association can be confirmed in a replication study, it will have a high confidence to be true positive. To design a replication study, traditional approaches calculate power by treating replication study as another independent primary study. These approaches do not use the information given by primary study. Besides, they need to specify a minimum detectable effect size, which may be subjective. One may think to replace the minimum effect size with the observed effect sizes in the power calculation. However, this approach will make the designed replication study underpowered since we are only interested in the positive associations from the primary study and the problem of the “winner’s curse” will occur. An Empirical Bayes (EB) based method is proposed to estimate the power of replication study for each association. The corresponding credible interval is estimated in the proposed approach. Simulation experiments show that our method is better than other plug-in based estimators in terms of overcoming the winner’s curse and providing higher estimation accuracy. The coverage probability of given credible interval is well-calibrated in the simulation experiments. Weighted average method is used to estimate the average power of all underlying true associations. This is used to determine the sample size of replication study. Sample sizes are estimated on 6 diseases from Wellcome Trust Case Control Consortium (WTCCC) using our method. They are higher than sample sizes estimated by plugging observed effect sizes in power calculation. Our new method can objectively determine replication study’s sample size by using information extracted from primary study. Also the winner’s curse is alleviated. Thus, it is a better choice when designing replication studies of GWAS. The R-package is available at: http://bioinformatics.ust.hk/RPower.html .
机译:复制研究是在全基因组关联研究(GWAS)中滤除假阳性的常用验证方法。如果可以在复制研究中确认某种关联,那么它具有很高的置信度,可以证明是真正的阳性。为了设计复制研究,传统方法通过将复制研究视为另一个独立的主要研究来计算功效。这些方法未使用基础研究提供的信息。此外,他们需要指定一个最小的可检测效果大小,这可能是主观的。有人可能会认为在功率计算中用观察到的效应尺寸来代替最小效应尺寸。但是,由于我们只对基础研究中的积极关联感兴趣,并且会出现“获胜者的诅咒”问题,因此这种方法会使设计的复制研究的功能不足。提出了一种基于经验贝叶斯(EB)的方法来估计每个关联的复制研究的能力。在提出的方法中估计了相应的可信区间。仿真实验表明,在克服获胜者的诅咒和提供更高的估算精度方面,我们的方法优于其他基于插件的估算器。给定可信区间的覆盖概率在模拟实验中得到了很好的校准。加权平均法用于估计所有基础真实关联的平均功效。这用于确定复制研究的样本量。使用我们的方法估算了来自惠康信托病例对照协会(WTCCC)的6种疾病的样本量。它们高于通过在功率计算中插入观察到的效应量而估算出的样本量。通过使用从主要研究中提取的信息,我们的新方法可以客观地确定重复研究的样本量。同时也减轻了获胜者的诅咒。因此,在设计GWAS的复制研究时,它是一个更好的选择。 R包可从以下网址获得:http://bioinformatics.ust.hk/RPower.html。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号